The DSC1 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from HeLa cells, engineered for targeted disruption of the DSC1 gene. DSC1 encodes desmocollin 1, a calcium-dependent cadherin integral to desmosomal junctions. This polyclonal knockout pool, generated via CRISPR/Cas9-mediated gene disruption, provides a heterogeneous loss-of-function model that reflects the genetic variability inherent in polyclonal editing, enabling robust analysis of desmosome-dependent processes without the constraints of clonal selection. The product is supplied as a population of edited cells, suitable for immediate expansion and experimental use.
HeLa cells, the host line for this knockout, are immortalized human cervical epithelial adenocarcinoma cells originally isolated from a 31-year-old African American woman. These cells contain integrated human papillomavirus 18 (HPV-18) sequences and are among the most widely used cell lines in biomedical research. HeLa cells exhibit epithelial characteristics, including the formation of adherens junctions and desmosomes, albeit often with altered adhesion properties due to their transformed nature. Their robust growth, ease of transfection, and well-characterized proteomic and genomic landscape make them an ideal platform for studying cell adhesion dynamics and cancer biology.
DSC1 functions as a core component of desmosomal plaques, mediating homophilic and heterophilic interactions with desmogleins (DSG1, DSG3) and other desmocollins (DSC2, DSC3) to establish strong cell-cell adhesion. Intracellularly, DSC1 recruits plakoglobin (JUP) and plakophilins (PKP1, PKP2, PKP3), which tether to desmoplakin (DSP), linking the complex to keratin intermediate filaments (KRT1, KRT10). This structural network is regulated by calcium signaling, protein kinase C, retinoic acid, and TGF-beta, while the transcription factor p63 acts upstream to promote DSC1 expression. Disruption of DSC1 therefore compromises desmosome assembly, weakening adhesion and impairing downstream signaling required for epidermal integrity and differentiation.
In the HeLa cell context, DSC1 knockout provides a powerful model to dissect desmosomal contributions to cancer progression. HeLa cells, despite their transformed state, retain the capacity to form desmosome-like structures, and loss of DSC1 can be used to study how compromised adhesion influences migration, invasion, and metastatic potential. Furthermore, because desmosomal proteins are often dysregulated in carcinomas, this model enables investigation of the interplay between cell-cell adhesion and oncogenic pathways. The polyclonal nature of the knockout population mimics tumor heterogeneity, offering insights into how varied DSC1 loss-of-function mutations affect cellular behavior.
Research applications for these knockout cells include quantitative assessment of desmosomal protein localization by immunofluorescence, biochemical analysis of desmosomal complex formation via co-immunoprecipitation and Western blotting for DSC1 and plakoglobin, and functional assays such as calcium-switch adhesion and scratch wound migration. The model is also suited for drug screening campaigns targeting desmosome stability, RT-qPCR profiling of keratinocyte differentiation markers, and flow cytometric measurement of cell surface cadherins. For additional details or technical support, please contact Ascent Research.
